Sun Pharmaceuticals to buy DUSA
Sun Pharma's shares have risen 40 percent this year, compared with a 20 percent rise in the Mumbai market index .
While big multinationals such as Abbott Laboratories and Sanofi SA have been buying out Indian drug companies at high valuations, Sun Pharma remains one of only a few Indian drugmakers that has successfully acquired overseas companies and made profits.
Sun Pharma shares closed down 0.54 percent at 696.55 rupees. The company also announced that its net profit fell 46.5 percent in the second quarter.